Cancer represents more than 200 different types of malignancies—diseases caused by the uncontrolled and destructive growth of cells. When cancer cells grow unregulated, they can develop into tumors, invade nearby parts of the body and spread throughout the body. Treatment generally involves some combination of chemotherapy, radiation therapy and surgery.
Nearly 1.7 million Americans will discover that they have cancer this year. This devastating disease is the second leading cause of death in the United States. But breakthroughs in medical science are gaining ground in the battle with cancer.
BRI is committed to bringing participation in clinical trials and new innovative treatments and therapies to people with cancer. Research at BRI focused on cancer includes:
Evaluating new cancer therapies through trials such as national chemotherapy prevention trials, cancer treatment trials and quality of life/symptom management trials.
Conducting basic science research to better understand the progression and mechanism of disease in cancer. BRI scientists are leveraging knowledge gained in laboratory research to develop new approaches to cancer treatment and prevention.